1Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43(10): 977–83.
2Ferreira, MA, O'Donovan, MC, Meng, YA, Jones, IR, Ruderfer, DM, Jones, L, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40(9): 1056–8.
3Erk, S, Meyer-Lindenberg, A, Schnell, K, von Boberfeld C, Opitz, Esslinger, C, Kirsch, P, et al. Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch Gen Psychiatry 2010; 67(8): 803–11.
4Roussos, P, Giakoumaki, SG, Georgakopoulos, A, Robakis, NK, Bitsios, P. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disord 2011; 13(3): 250–9.
5Jakobsson, J, Palsson, E, Sellgren, C, Rydberg, F, Ekman, A, Zetterberg, H, et al. CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder. Br J Psychiatry 2016; 208(2): 195–6.
6Rolstad, S, Jakobsson, J, Sellgren, C, Ekman, CJ, Blennow, K, Zetterberg, H, et al. Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls. PLoS One 2015; 10(5): e0127100.
7Sachs, GS, Thase, ME, Otto, MW, Bauer, M, Miklowitz, D, Wisniewski, SR, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2003; 53: 1028–42.
8Kübler, U. Structured Clinical Interview for DSM-IV (SCID). In Encyclopedia of Behavioral Medicine (eds Gellman, MD, Turner, JR): 1919–1920. Springer, 2013.
9Pang, PT, Teng, HK, Zaitsev, E, Woo, NT, Sakata, K, Zhen, S, et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004; 306(5695): 487–91.
10Chao, MV, Bothwell, M. Neurotrophins: to cleave or not to cleave. Neuron 2002; 33(1): 9–12.
11Sodersten, K, Palsson, E, Ishima, T, Funa, K, Landen, M, Hashimoto, K, et al. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. J Affect Disord 2014; 160: 1–9.
12Yang, B, Ren, Q, Zhang, JC, Chen, QX, Hashimoto, K. Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis. Transl Psychiatry 2017; 7(5): e1128.
13Jiang, H, Chen, S, Li, C, Lu, N, Yue, Y, Yin, Y, et al. The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment. Transl Psychiatry 2017; 7(4): e1079.
14Hashimoto, R, Takei, N, Shimazu, K, Christ, L, Lu, B, Chuang, DM. Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology 2002; 43(7): 1173–9.
15Shieh, PB, Hu, SC, Bobb, K, Timmusk, T, Ghosh, A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 1998; 20(4): 727–40.
16Zhang, H, Fu, Y, Altier, C, Platzer, J, Surmeier, DJ, Bezprozvanny, I. Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. Eur J Neurosci 2006; 23(9): 2297–310.
17Dao, DT, Mahon, PB, Cai, X, Kovacsics, CE, Blackwell, RA, Arad, M, et al. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biol Psychiatry 2010; 68(9): 801–10.